Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials 22 Nov Dr D Open label evaluation of cannabidiol in dystonic movement disorders. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.